Europäische Union - Slowenisch - EMA (European Medicines Agency)

biolitec pharma ltd - temoporfin - head and neck neoplasms; carcinoma, squamous cell - antineoplastična sredstva - foscan je indiciran za paliativno zdravljenje bolnikov z napredovalim karcinomom skvamoznih celic glave in vratu, ki niso prejeli terapije in niso primerni za radioterapijo, kirurgijo ali sistemsko kemoterapijo.

Europäische Union - Slowenisch - EMA (European Medicines Agency)

pinnacle biologics b.v.  - natrijev porfimer - barrett požiralnik - antineoplastična sredstva - fotodinamična terapija (pdt) z photobarr je indiciran za: ablacijo visoko-kakovostni razred displazija (hgd) pri bolnikih z barrett je požiralniku (eo).

Europäische Union - Slowenisch - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastična sredstva - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Europäische Union - Slowenisch - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - levkemija, mielogena, kronična, bcr-abl pozitivna - antineoplastična sredstva - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

Slowenien - Slowenisch - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenis d.o.o. - streptokinaza - prašek za raztopino za injiciranje/infundiranje - streptokinaza 250000 i.e. / 1 viala - streptokinaza

Slowenien - Slowenisch - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenis d.o.o. - streptokinaza - prašek za raztopino za infundiranje - streptokinaza 750000 i.e. / 1 viala - streptokinaza

Slowenien - Slowenisch - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanolabor, d.d. - prašek za raztopino za infundiranje - streptokinaza

Europäische Union - Slowenisch - EMA (European Medicines Agency)

takeda pharma a/s - brigatinib - karcinom, pljučni pljuč - antineoplastična sredstva - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.

Europäische Union - Slowenisch - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinalni stromalni tumorji - antineoplastična sredstva - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Europäische Union - Slowenisch - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - palifermin - mucositis - vsi drugi terapevtski izdelki - kepivance je indicirano za zmanjšanje pogostosti, trajanje in resnost ustni mukolitis pri odraslih bolnikih z hematološke maligne prejemajo myeloablative pooperativne radioterapije, povezane z visoko incidenco hudo mukolitis in zahteva podporo avtologni-hematopoetske-izvornih celic.